14-34711567-AAAG-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_138638.5(CFL2):c.*1295_*1297del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 454,326 control chromosomes in the GnomAD database, including 55 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.014 ( 24 hom., cov: 33)
Exomes 𝑓: 0.011 ( 31 hom. )
Consequence
CFL2
NM_138638.5 3_prime_UTR
NM_138638.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.41
Genes affected
CFL2 (HGNC:1875): (cofilin 2) This gene encodes an intracellular protein that is involved in the regulation of actin-filament dynamics. This protein is a major component of intranuclear and cytoplasmic actin rods. It can bind G- and F-actin in a 1:1 ratio of cofilin to actin, and it reversibly controls actin polymerization and depolymerization in a pH-dependent manner. Mutations in this gene cause nemaline myopathy type 7, a form of congenital myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 14-34711567-AAAG-A is Benign according to our data. Variant chr14-34711567-AAAG-A is described in ClinVar as [Benign]. Clinvar id is 313084.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0139 (2121/152314) while in subpopulation AFR AF= 0.0172 (715/41562). AF 95% confidence interval is 0.0162. There are 24 homozygotes in gnomad4. There are 1021 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 24 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFL2 | NM_138638.5 | c.*1295_*1297del | 3_prime_UTR_variant | 4/4 | ENST00000298159.11 | NP_619579.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFL2 | ENST00000298159.11 | c.*1295_*1297del | 3_prime_UTR_variant | 4/4 | 1 | NM_138638.5 | ENSP00000298159 | P1 | ||
CFL2 | ENST00000341223.8 | c.*1295_*1297del | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000340635 | P1 | |||
CFL2 | ENST00000672517.1 | c.*1295_*1297del | 3_prime_UTR_variant | 5/5 | ENSP00000500532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0139 AC: 2117AN: 152196Hom.: 24 Cov.: 33
GnomAD3 genomes
AF:
AC:
2117
AN:
152196
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0110 AC: 1498AN: 136478Hom.: 13 AF XY: 0.0105 AC XY: 779AN XY: 74096
GnomAD3 exomes
AF:
AC:
1498
AN:
136478
Hom.:
AF XY:
AC XY:
779
AN XY:
74096
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0113 AC: 3420AN: 302012Hom.: 31 AF XY: 0.0108 AC XY: 1857AN XY: 172120
GnomAD4 exome
AF:
AC:
3420
AN:
302012
Hom.:
AF XY:
AC XY:
1857
AN XY:
172120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0139 AC: 2121AN: 152314Hom.: 24 Cov.: 33 AF XY: 0.0137 AC XY: 1021AN XY: 74486
GnomAD4 genome
AF:
AC:
2121
AN:
152314
Hom.:
Cov.:
33
AF XY:
AC XY:
1021
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nemaline Myopathy, Recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at